GlassScriptPhysician profile
Rachael White Greer
NPI 1043841265
$6,720.45
in general payments reported to CMS, 2019-2025
52 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,371 · 2022: $2,015 · 2023: $1,991 · 2024: $1,239 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,334.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $813.66 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $442.83 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $441.32 | 2021-2024 | Jakafi, Monjuvi |
| Janssen Biotech, INC. | $356.28 | 2021-2024 | Darzalex, Tecvayli, Talvey |
| Genzyme Corporation | $342.01 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $308.60 | 2021-2024 | Imfinzi, Enhertu, Lynparza |
| Genentech USA, INC. | $271.85 | 2021-2024 | Venclexta, Polivy |
| Amgen INC. | $252.72 | 2021-2023 | Lumakras |
| Daiichi Sankyo INC. | $227.25 | 2021-2024 | Enhertu |
| Pfizer INC. | $221.65 | 2021-2025 | |
| Lilly USA, LLC | $208.87 | 2021-2024 | Jaypirca, Verzenio, Retevmo |
| Deciphera Pharmaceuticals INC. | $185.44 | 2021-2024 | Qinlock |
| Celgene Corporation | $168.06 | 2022-2024 | Reblozyl, Pomalyst |
| Beigene USA, INC. | $161.64 | 2021-2024 | Brukinsa |
| Astellas Pharma US INC | $149.91 | 2021-2024 | Padcev, Xospata |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachael Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.